"10.1371_journal.pone.0096629","plos one","2014-05-21T00:00:00Z","Carsten Eggers; Frank Schwartz; David J Pedrosa; Lutz Kracht; Lars Timmermann","Department of Neurology, University Hospital of Cologne, Cologne, Germany; Max-Planck-Institute for Neurological Research, Cologne, Germany","Conceived and designed the experiments: CE LT. Performed the experiments: CE FS. Analyzed the data: CE FS DP. Contributed reagents/materials/analysis tools: CE LK. Wrote the paper: CE FS LT.","Additionally the authors would like to state that three authors do have competing interests/affiliations with commercial companys. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials. As stated in the manuscript, the competing interests are as following: CE occasionally received honoraria from Medtronic Inc., TEVA Pharma and UCB Pharma for lecturing at conferences or consulting work. The institution of CE, not CE personally, received funding by the German Research Foundation (DFG), Köln Fortune, Medtronic Inc., Bayer Healthcare, UCB Pharma, Abbott, Zur Rose Pharma. DP occasionally received honoraria from Medtronic Inc. and Bayer Healthcare for lecturing at conferences or consulting work. LT received payments as a consultant for Medtronic Inc., Boston Scientific, Bayer Healthcare, UCB Schwarz Pharma and Sapiens. LT received honoraria as a speaker on symposia sponsored by TEVA Pharma, Lundbeck Pharma, Bracco, Gianni PR, Medas Pharma, UCB Schwarz Pharma, Desitin Pharma, Boehringer Ingelheim, GlaxoSmithKline, Eumecom, Orion Pharma, Medtronic Inc., Boston Scientific, Cephalon, Abott, GE Medical. The institution of LT, not LT personally, received funding by the German Research Foundation (DFG), the German Ministry of Education and Research, Manfred und Ursula Müller Stiftung, Klüh Stiftung, Hoffnungsbaum e. V., NBIA DISORDERS SOCIETY United States of America, Köln Fortune, Medtronic Inc., UCB Schwarz Pharma, Bayer Healthcare, Zur Rose Pharma, Abbvie, Archimedes Teva and Deutsche Parkinson Vereinigung. Apart from the above, the authors report no financial conflict of interest and do not have to disclose any commercial considerations, such as an equity interest, patent rights, or corporate affiliation, including consultantships, for any product or process mentioned in the submission.","2014","05","Carsten Eggers","CE",5,TRUE,2,2,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
